comprehensive -WSS

comprehensive

author：hotspot 2025-09-28 20:44:32 - browse：83

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： NIH trials fail to test meaningful long Covid therapies, experts say

WSS

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Wegovy trial has doctors encouraged over new possibilities

Readout LOUD podcast: mifepristone case, GLP

In same hospitals, Black patients receive fewer opioids than white patients

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

focus

comprehensive

explore

Apple is now the first public company to be valued at $3 trillion

FDA panel issues narrow recommendation for Covid vaccine booster doses

Novavax promises a turnaround & Lilly roils the obesity market

Wegovy’s successful heart trial raises vital question about weight loss

Walensky prepares to leave CDC — and Congress — behind

Why the world’s most expensive drug might be worth the price

Tori Bowie and the unacceptable rates of Black maternal death

Why failed clinical trials don’t always spell doom for a new drug

Medical leaders decry Supreme Court decision on affirmative action

Wegovy trial has doctors encouraged over new possibilities

hotspot

Oprah kicked off a national conversation on obesity. Let's have it

Eliminate the waiting period for sterilization covered by Medicaid

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Eliminate the waiting period for sterilization covered by Medicaid

Will generative AI in health care meet the fate of IBM's Dr. Watson?

How to use technology to prevent future drug shortages

focus

entertainment

Wikipedia

hotspot